 | Up a level |
Morel, Victoria Judith; Rössler, Jochen; Bernasconi, Michele (2024). Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future. (In Press). Medicinal research reviews Wiley 10.1002/med.22059
Dzhumashev, Dzhangar; Anton-Joseph, Stenija; Morel, Victoria J; Timpanaro, Andrea; Bordon, Gregor; Piccand, Caroline; Aleandri, Simone; Luciani, Paola; Rössler, Jochen; Bernasconi, Michele (2024). Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells. European journal of pharmaceutics and biopharmaceutics, 194, pp. 49-61. Elsevier 10.1016/j.ejpb.2023.11.020
Timpanaro, Andrea; Piccand, Caroline; Dzhumashev, Dzhangar; Anton Joseph, Stenija; Robbi, Andrea; Moser, Janine; Rössler, Jochen; Bernasconi, Michele (2023). CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models. Journal of experimental & clinical cancer research, 42(1), p. 293. BioMed Central 10.1186/s13046-023-02838-3
Timpanaro, Andrea; Piccand, Caroline; Uldry, Anne-Christine; Bode, Peter Karl; Dzhumashev, Dzhangar; Sala, Rita; Heller, Manfred; Rössler, Jochen; Bernasconi, Michele (2023). Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. International journal of molecular sciences, 24(3), p. 2601. MDPI 10.3390/ijms2403260
Timpanaro, Andrea; Piccand, Caroline; Uldry, Anne-Christine; Bode, Peter Karl; Dzhumashev, Dzhangar; Sala, Rita; Heller, Manfred; Rössler, Jochen Karl; Bernasconi, Michele (2023). Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. International journal of molecular sciences, 24(3) MDPI 10.3390/ijms24032601
Dzhumashev, Dzhangar; Timpanaro, Andrea; Ali, Safa; De Micheli, Andrea J; Mamchaoui, Kamel; Cascone, Ilaria; Rössler, Jochen K; Bernasconi, Michele (2022). Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma. Cancers, 14(20) MDPI AG 10.3390/cancers14205048
Sidorov, Semjon; Fux, Lara; Steiner, Katja; Bounlom, Samyo; Traxel, Sabrina; Azzi, Tarik; Berisha, Arbeneshe; Berger, Christoph; Bernasconi, Michele; Niggli, Felix K; Perner, Yvonne; Pather, Sugeshnee; Kempf, Werner; Nadal, David; Bürgler, Simone (2022). CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes. Cancer immunology, immunotherapy : CII, 71(6), pp. 1371-1392. Springer 10.1007/s00262-021-03057-5
Alijaj, Nagjie; Moutel, Sandrine; Gouveia, Zelia L; Gray, Maxim; Roveri, Maurizio; Dzhumashev, Dzhangar; Weber, Florian; Meier, Gianmarco; Luciani, Paola; Rössler, Jochen K.; Schäfer, Beat W; Perez, Franck; Bernasconi, Michele (2020). Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers, 12(11) MDPI AG 10.3390/cancers12113313
